It’s Time To Focus On The Long Run With Myriad Genetics Inc. (MYGN) stock

The closing price of Myriad Genetics Inc. (NASDAQ: MYGN) was $19.59 for the day, up 3.05% from the previous closing price of $19.01. In other words, the price has increased by $+0.58 from its previous closing price. On the day, 864276 shares were traded. MYGN stock price reached its highest trading level at $19.68 during the session, while it also had its lowest trading level at $18.58.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".



Our analysis of MYGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.60 and its Current Ratio is at 2.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On October 06, 2022, Stephens started tracking the stock assigning a Equal-Weight rating and target price of $22.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 20 when Riggsbee Richard Bryan sold 9,400 shares for $20.04 per share. The transaction valued at 188,386 led to the insider holds 364,107 shares of the business.

Riggsbee Richard Bryan sold 600 shares of MYGN for $12,006 on Jan 18. The Chief Financial Officer now owns 373,507 shares after completing the transaction at $20.01 per share. On Dec 27, another insider, Riggsbee Richard Bryan, who serves as the Chief Financial Officer of the company, sold 20,000 shares for $15.15 each. As a result, the insider received 302,992 and left with 374,107 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 2.50 while its Price-to-Book (P/B) ratio in mrq is 1.72.

Stock Price History:

Over the past 52 weeks, MYGN has reached a high of $28.18, while it has fallen to a 52-week low of $13.92. The 50-Day Moving Average of the stock is 18.32, while the 200-Day Moving Average is calculated to be 20.35.

Shares Statistics:

MYGN traded an average of 724.58K shares per day over the past three months and 539.57k shares per day over the past ten days. A total of 80.70M shares are outstanding, with a floating share count of 79.43M. Insiders hold about 3.00% of the company’s shares, while institutions hold 98.17% stake in the company. Shares short for MYGN as of Oct 13, 2022 were 3.81M with a Short Ratio of 3.21M, compared to 3.93M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 4.73% and a Short% of Float of 6.83%.

Earnings Estimates

The firm’s stock currently is rated by 9 analysts. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of $0.02 and a low estimate of -$0.22, while EPS last year was -$0.02. The consensus estimate for the next quarter is -$0.01, with high estimates of $0.03 and low estimates of -$0.02.

Analysts are recommending an EPS of between $0.05 and -$0.19 for the fiscal current year, implying an average EPS of -$0.06. EPS for the following year is $0.11, with 9 analysts recommending between $0.31 and $0.

Revenue Estimates

A total of 10 analysts have provided revenue estimates for MYGN’s current fiscal year. The highest revenue estimate was $700M, while the lowest revenue estimate was $685.49M, resulting in an average revenue estimate of $692.18M. In the same quarter a year ago, actual revenue was $690.6M, up 0.20% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $739.42M in the next fiscal year. The high estimate is $765M and the low estimate is $716.18M. The average revenue growth estimate for next year is up 6.80% from the average revenue estimate for this year.